|Day Low/High||36.97 / 37.87|
|52 Wk Low/High||33.88 / 64.50|
U.S. stock losses accelerated throughout the morning after a reading on manufacturing activity in the U.S. fell into contraction.
Accounting irregularities lead to some troubling scenarios.
It's apparently not all doom and gloom in the private-equity realm of stock picking these days.
Appaloosa adds to its stake in the biopharmaceutical company while Jana Partners exits its position.
Macy's plans to close stores and Jim Cramer thinks the stock is one to trade.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Ralph Lauren shares surge on earnings beat amid lethargic market action.
Plus, hats off to Fill or Kill on Lululemon.
Analysts say Tuesday's earnings beat could spell trouble in terms of coping with its $31 billion worth of debt.
All eyes will be on whether the drug company cuts its earnings guidance in tomorrow's earnings release.
It has had a long correction, but a resolution up or down is coming
The Canadian drugmaker could again be hit by its unprofitable Walgreens deal as earnings loom.
U.S. stocks struggle to hold onto slight gains after a terrorist attack overnight casts a shadow over global markets.
Herbalife stock lifted on FTC investigation results while Xerox reportedly rejects R.R. Donnelley's merger proposal.
Costco and Zumiez were able to benefit from their strong June comps, while Walgreens Buckle and L Brands went the other way.
U.S. stocks shook off earlier weakness to close higher after the Fed's June meeting minutes stressed a prudent approach to monetary policy.
U.S. stocks moved lower on Wednesday, as Brexit fears pushed investors into safe-haven assets.
Walgreens reports mixed quarterly results, Nortek bought for $2.8 billion as stocks point lower.
On Wednesday, July 6, investors will get the minutes of the Federal Reserve's June meeting and earnings from Walgreens.
For the week of July 4, investors await earnings from Walgreens Boots Alliance, the FOMC minutes and the June jobs report.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on earnings from Walgreens Boots Alliance and PepsiCo, released next week.
The federal government has turned violently against these deals.
There are some good plays out there, but no one seems to want the ball in this gameless market.
Without it, any rally would just be a short-covering bump.
When a stock like WBA isn't trading at a discount, try put options.
The troubled Canadian drugmaker is under increased pressure to sell assets, and quickly.
Sad weekend. Sad day. The big business news item -- Microsoft (MSFT) acquiring LinkedIn (LNKD), but I don't view this as a meaningful positive. I added to my Nasdaq short today at attractive prices. "Trade of the Week" -- long Twitter (TWTR). Odd...
Papa is set to meet with Walgreens management in hopes of ironing out "speed bumps."
Walgreens formally ended its relationship with Theranos.